Search

everythinglearnresearchcommunity

for

Search:↓

The yeast Pityrosporum ovale can cause skin allergies and infections, and antifungal treatments like ketoconazole are effective against it.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Cholesterol sulfate buildup due to a genetic mutation disrupts the skin barrier, leading to the scaling skin seen in X-linked ichthyosis.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

Diazoxide, minoxidil sulphate, and cromakalim relax rat blood vessels by opening K+ channels, with some differences in their actions.

Circadian rhythms are crucial for stem cell function and tissue repair, and understanding them may improve aging and regeneration treatments.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Drosha and Dicer are essential for hair follicle health and preventing DNA damage in skin cells.

Drugs penetrate scalp skin better than abdominal skin, with scalp hair follicles aiding in higher drug delivery.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Memantine may slightly improve memory in people with Down syndrome, but more research is needed.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Melatonin helps hair growth in women with hair loss.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Liver transplantation is a viable option for children with propionic acidemia, improving quality of life and diet, but does not remove all risks and long-term brain outcomes are uncertain.

Restoring mitochondrial function in mice reversed their skin wrinkling and hair loss.

Human hair follicle stem cells can turn into multiple cell types but lose some of this ability after being grown in the lab for a long time.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Minoxidil and finasteride treat hair loss; more research needed for other options.